---
figid: PMC7598629__cancers-12-02751-g001
figlink: pmc/articles/PMC7598629/figure/cancers-12-02751-f001/
number: Figure 1
caption: 'PI3K/AKT/mTOR signalling pathway SMIs for the treatment of endometrial cancer.
  Current SMIs under clinical investigation and their target molecules are displayed.
  Abbreviations: RTK, Receptor Tyrosine Kinase.'
pmcid: PMC7598629
papertitle: Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy
  for Endometrial Cancer.
reftext: Cristina Megino-Luque, et al. Cancers (Basel). 2020 Oct;12(10):2751.
pmc_ranked_result_index: '2325'
pathway_score: 0.9050466
filename: cancers-12-02751-g001.jpg
figtitle: PI3K/AKT/mTOR signalling pathway SMIs for the treatment of endometrial cancer
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7598629__cancers-12-02751-g001.html
  '@type': Dataset
  description: 'PI3K/AKT/mTOR signalling pathway SMIs for the treatment of endometrial
    cancer. Current SMIs under clinical investigation and their target molecules are
    displayed. Abbreviations: RTK, Receptor Tyrosine Kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLP2
  - PTEN
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PDK1
  - AKT2
  - AKT3
  - AKT1
  - SAR245408
  - NVP BLY719
  - AZD5363
  - AZD2014
  - AZD8055
  - Sapanisertib
  - Everolimus
  - RADO01
  - Temserolimus
  - Ridaforolimus
  - Deforolimus
  - AP23573
  - BEZ235
  - GDC-0980
  - PF05212384
genes:
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: SAR245408
  source: MESH
  identifier: C581157
- word: NVP BLY719
  source: MESH
  identifier: C585539
- word: AZD5363
  source: MESH
  identifier: C575618
- word: AZD2014
  source: MESH
  identifier: C585537
- word: AZD8055
  source: MESH
  identifier: C546624
- word: Sapanisertib
  source: ''
  identifier: ''
- word: Everolimus
  source: MESH
  identifier: C107135
- word: RADO01
  source: MESH
  identifier: C519584
- word: Temserolimus
  source: ''
  identifier: ''
- word: Ridaforolimus
  source: MESH
  identifier: C515074
- word: Deforolimus
  source: MESH
  identifier: C515074
- word: AP23573
  source: ''
  identifier: ''
- word: BEZ235
  source: MESH
  identifier: C531198
- word: GDC-0980
  source: MESH
  identifier: C569670
- word: PF05212384
  source: MESH
  identifier: C549060
diseases: []
---
